Fat Mass and Obesity Associated () Gene and Hepatic Glucose and Lipid Metabolism

Overview

Journal Nutrients

Date 2018 Nov 4

PMID 30388740

Citations 50

Authors

Tooru M Mizuno

Affiliations

Soon will be listed here.

Abstract

Common genetic variants of the fat mass and obesity associated () gene are strongly associated with obesity and type 2 diabetes. FTO is ubiquitously expressed. Earlier studies have focused on the role of hypothalamic FTO in the regulation of metabolism. However, recent studies suggest that expression of hepatic FTO is regulated by metabolic signals, such as nutrients and hormones, and altered FTO levels in the liver affect glucose and lipid metabolism. This review outlines recent findings on hepatic FTO in the regulation of metabolism, with particular focus on hepatic glucose and lipid metabolism. It is proposed that abnormal activity of hepatic signaling pathways involving FTO links metabolic impairments such as obesity, type 2 diabetes and nonalcoholic fatty liver disease (NAFLD). Therefore, a better understanding of these pathways may lead to therapeutic approaches to treat these metabolic diseases by targeting hepatic FTO. The overall goal of this review is to place FTO within the context of hepatic regulation of metabolism.

Citing Articles

Lipids dysregulation in diseases: core concepts, targets and treatment strategies.

Dakal T, Xiao F, Bhusal C, Sabapathy P, Segal R, Chen J Lipids Health Dis. 2025; 24(1):61.

PMID: 39984909 PMC: 11843775. DOI: 10.1186/s12944-024-02425-1.

Therapeutic Potential of FTO Demethylase in Metabolism and Disease Pathways.

Somala C, Sathyapriya S, Bharathkumar N, Anand T, Mathangi D, Saravanan K Protein J. 2025; 44(1):21-34.

PMID: 39923206 DOI: 10.1007/s10930-025-10250-3.

The Role of FTO Risk Haplotype in Overweight/Obesity and Lipid Parameters-Results From the Central China Population Study.

Ning M, Chen L, Wang Y, Xu A, Zeng R, Zhang H Int J Endocrinol. 2024; 2024:8062791.

PMID: 39483856 PMC: 11527535. DOI: 10.1155/2024/8062791.

Diet-induced Obesity: Pathophysiology, Consequences and Target Specific Therapeutic Strategies.

Banerjee M, Pandey V Curr Protein Pept Sci. 2024; 26(2):113-124.

PMID: 39225225 DOI: 10.2174/0113892037329528240827180820.

Exosome prospects in the diagnosis and treatment of non-alcoholic fatty liver disease.

Tamimi A, Javid M, Sedighi-Pirsaraei N, Mirdamadi A Front Med (Lausanne). 2024; 11:1420281.

PMID: 39144666 PMC: 11322140. DOI: 10.3389/fmed.2024.1420281.

References

Tung Y, Gulati P, Liu C, Rimmington D, Dennis R, Ma M . FTO is necessary for the induction of leptin resistance by high-fat feeding. Mol Metab. 2015; 4(4):287-98. PMC: 4354923. DOI: 10.1016/j.molmet.2015.01.011. View

Wu Q, Saunders R, Szkudlarek-Mikho M, de la Serna I, Chin K . The obesity-associated Fto gene is a transcriptional coactivator. Biochem Biophys Res Commun. 2010; 401(3):390-5. PMC: 2963669. DOI: 10.1016/j.bbrc.2010.09.064. View

Lim A, Zhou J, Sinha R, Singh B, Ghosh S, Lim K . Hepatic FTO expression is increased in NASH and its silencing attenuates palmitic acid-induced lipotoxicity. Biochem Biophys Res Commun. 2016; 479(3):476-481. DOI: 10.1016/j.bbrc.2016.09.086. View

Zhang Y, Guo F, Zhao R . Hepatic expression of FTO and fatty acid metabolic genes changes in response to lipopolysaccharide with alterations in mA modification of relevant mRNAs in the chicken. Br Poult Sci. 2016; 57(5):628-635. DOI: 10.1080/00071668.2016.1201199. View

Poritsanos N, Lew P, Mizuno T . Relationship between blood glucose levels and hepatic Fto mRNA expression in mice. Biochem Biophys Res Commun. 2010; 400(4):713-7. DOI: 10.1016/j.bbrc.2010.08.133. View

Sanghera D, Ortega L, Han S, Singh J, Ralhan S, Wander G . Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet. 2008; 9:59. PMC: 2481250. DOI: 10.1186/1471-2350-9-59. View

Stratigopoulos G, Padilla S, LeDuc C, Watson E, Hattersley A, McCarthy M . Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol. 2008; 294(4):R1185-96. PMC: 2808712. DOI: 10.1152/ajpregu.00839.2007. View

Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P . Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007; 39(6):724-6. DOI: 10.1038/ng2048. View

Meyer K, Saletore Y, Zumbo P, Elemento O, Mason C, Jaffrey S . Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons. Cell. 2012; 149(7):1635-46. PMC: 3383396. DOI: 10.1016/j.cell.2012.05.003. View

10.

Tiwari A, Krzysik-Walker S, Ramachandran R . Cloning and characterization of chicken fat mass and obesity associated (Fto) gene: fasting affects Fto expression. Domest Anim Endocrinol. 2011; 42(1):1-10. DOI: 10.1016/j.domaniend.2011.08.001. View

11.

Mendez-Lucas A, Hyrossova P, Novellasdemunt L, Vinals F, Perales J . Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availability. J Biol Chem. 2014; 289(32):22090-102. PMC: 4139223. DOI: 10.1074/jbc.M114.566927. View

12.

Scuteri A, Sanna S, Chen W, Uda M, Albai G, Strait J . Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007; 3(7):e115. PMC: 1934391. DOI: 10.1371/journal.pgen.0030115. View

13.

Ronkainen J, Huusko T, Soininen R, Mondini E, Cinti F, Makela K . Fat mass- and obesity-associated gene Fto affects the dietary response in mouse white adipose tissue. Sci Rep. 2015; 5:9233. PMC: 4363842. DOI: 10.1038/srep09233. View

14.

Caruso V, Chen H, Morris M . Early hypothalamic FTO overexpression in response to maternal obesity--potential contribution to postweaning hyperphagia. PLoS One. 2011; 6(9):e25261. PMC: 3182187. DOI: 10.1371/journal.pone.0025261. View

15.

Chen B, Ye F, Yu L, Jia G, Huang X, Zhang X . Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. J Am Chem Soc. 2012; 134(43):17963-71. DOI: 10.1021/ja3064149. View

16.

Guo F, Zhang Y, Zhang C, Wang S, Ni Y, Zhao R . Fatmass and obesity associated (FTO) gene regulates gluconeogenesis in chicken embryo fibroblast cells. Comp Biochem Physiol A Mol Integr Physiol. 2014; 179:149-56. DOI: 10.1016/j.cbpa.2014.10.003. View

17.

Yajnik C, Janipalli C, Bhaskar S, Kulkarni S, Freathy R, Prakash S . FTO gene variants are strongly associated with type 2 diabetes in South Asian Indians. Diabetologia. 2008; 52(2):247-52. PMC: 2658005. DOI: 10.1007/s00125-008-1186-6. View

18.

Church C, Lee S, Bagg E, McTaggart J, Deacon R, Gerken T . A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene. PLoS Genet. 2009; 5(8):e1000599. PMC: 2719869. DOI: 10.1371/journal.pgen.1000599. View

19.

Wang C, Li H, Meng Q, Du Y, Xiao F, Zhang Q . ATF4 deficiency protects hepatocytes from oxidative stress via inhibiting CYP2E1 expression. J Cell Mol Med. 2013; 18(1):80-90. PMC: 3916120. DOI: 10.1111/jcmm.12166. View

20.

Wahlen K, Sjolin E, Hoffstedt J . The common rs9939609 gene variant of the fat mass- and obesity-associated gene FTO is related to fat cell lipolysis. J Lipid Res. 2007; 49(3):607-11. DOI: 10.1194/jlr.M700448-JLR200. View